drugset / Trial / NCT03407495
The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular Carcinoma
NaSingle-groupOpen-labelDiagnostic
Summary
This study is an exploratory study aiming to collect data on sensitivity and positive predictive value of IOP-enhanced (MPB-1523) MRI compared to dynamic multiphase MDCT for the detection of HCC.
Timeline
- Start
- 2018-11-22
- Primary completion
- 2020-08-30
- Completion
- 2020-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MPB-1523 | Diagnostic / imaging agent | — | Intravenous |
Indications
No indication recorded.